Company Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
Equities
688336
CNE1000062X2
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.12 CNY | +0.74% |
|
+1.43% | -15.06% |
Apr. 25 | Sunshine Guojian Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 21 | Sunshine Guojian Pharmaceutical's Profit Surges Sixfold in 2023 | MT |
Business Summary
Number of employees: 965
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody Drugs
100.0
%
| 825 | 100.0 % | 1,014 | 100.0 % | +22.84% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
99.3
%
| 795 | 97.2 % | 1,007 | 99.3 % | +26.66% |
Other Countries
0.7
%
| 23 | 2.8 % | 7 | 0.7 % | -68.50% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 616,785,793 | 81,199,275 ( 13.16 %) | 0 | 13.16 % |
Company contact information
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
399 Libing Road Shanghai Free Trade Zone
201203, Shanghai
+
http://www.3s-guojian.com![address Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd(688336)](https://cdn.zonebourse.com/static/address/156796616.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.06% | 1.61B | |
+7.46% | 100B | |
+11.97% | 42.34B | |
-11.76% | 32.76B | |
+79.34% | 29.46B | |
-12.20% | 16.31B | |
+4.00% | 14.39B | |
-1.90% | 12.23B | |
+178.17% | 10.47B | |
+1.80% | 8.97B |
- Stock Market
- Equities
- 688336 Stock
- Company Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd